Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjian Min

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Acta Pharmaceutica Sinica. B|February 13, 2026
From concept to application: Exploring the evolution and potential of DUBTAC technologyDanfeng Wang, Wenjian Min, Binjian Jiang, et al.
Acta Pharmaceutica Sinica. B|February 3, 2021
Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugsKai Yuan, Xiao Wang, Haojie Dong, et al.
Bioorganic Chemistry|June 28, 2021
Computational discovery, structural optimization and biological evaluation of novel inhibitors targeting transient receptor potential vanilloid type 3 (TRPV3)Fang Zhang, Yiyu Lin, Wenjian Min, et al.
Journal of Medicinal Chemistry|January 2, 2026
A Multifunctional Prodrug with the DNA Damage Amplification Effect for Inducing Immunogenic Cell DeathHaolin Zhang, Guisen Li, Chunling Chen, et al.
European Journal of Medicinal Chemistry|August 6, 2023
Targeting polyketide synthase 13 for the treatment of tuberculosisFei Xia, Haoling Zhang, Huanaoyu Yang, et al.
Future Medicinal Chemistry|May 14, 2020
Discovery of novel and selective CDK4/6 inhibitors by pharmacophore and structure-based virtual screeningKai Yuan, Wenjian Min, Xiao Wang, et al.
Science China. Life Sciences|November 9, 2020
Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53Xiaoxiao Liu, Li Zhang, Pyone Myat Thu, et al.
Journal of Medicinal Chemistry|November 17, 2025
Structure-Guided Design of a Highly Selective PI3Kα Inhibitor Overcoming Metabolic Dysregulation with Potent Anti-breast Cancer EfficacyYi Hou, Han Qin, Xinqing Zheng, et al.
Chinese Journal of Natural Medicines|March 23, 2025
Recent advances in regulating the cell cycle through inhibiting CDKs for cancer treatmentWeijiao Chen, Xujie Zhuang, Yuanyuan Chen, et al.
Acta Pharmaceutica Sinica. B|June 27, 2022
Development and clinical advancement of small molecules for <i>ex vivo</i> expansion of hematopoietic stem cellJiaxing Li, Xiao Wang, Jiayu Ding, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Acta Pharmaceutica Sinica. B|February 13, 2026
From concept to application: Exploring the evolution and potential of DUBTAC technologyDanfeng Wang, Wenjian Min, Binjian Jiang, et al.
Acta Pharmaceutica Sinica. B|February 3, 2021
Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugsKai Yuan, Xiao Wang, Haojie Dong, et al.
Bioorganic Chemistry|June 28, 2021
Computational discovery, structural optimization and biological evaluation of novel inhibitors targeting transient receptor potential vanilloid type 3 (TRPV3)Fang Zhang, Yiyu Lin, Wenjian Min, et al.
Journal of Medicinal Chemistry|January 2, 2026
A Multifunctional Prodrug with the DNA Damage Amplification Effect for Inducing Immunogenic Cell DeathHaolin Zhang, Guisen Li, Chunling Chen, et al.
European Journal of Medicinal Chemistry|August 6, 2023
Targeting polyketide synthase 13 for the treatment of tuberculosisFei Xia, Haoling Zhang, Huanaoyu Yang, et al.
Future Medicinal Chemistry|May 14, 2020
Discovery of novel and selective CDK4/6 inhibitors by pharmacophore and structure-based virtual screeningKai Yuan, Wenjian Min, Xiao Wang, et al.
Science China. Life Sciences|November 9, 2020
Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53Xiaoxiao Liu, Li Zhang, Pyone Myat Thu, et al.
Journal of Medicinal Chemistry|November 17, 2025
Structure-Guided Design of a Highly Selective PI3Kα Inhibitor Overcoming Metabolic Dysregulation with Potent Anti-breast Cancer EfficacyYi Hou, Han Qin, Xinqing Zheng, et al.
Chinese Journal of Natural Medicines|March 23, 2025
Recent advances in regulating the cell cycle through inhibiting CDKs for cancer treatmentWeijiao Chen, Xujie Zhuang, Yuanyuan Chen, et al.
Acta Pharmaceutica Sinica. B|June 27, 2022
Development and clinical advancement of small molecules for <i>ex vivo</i> expansion of hematopoietic stem cellJiaxing Li, Xiao Wang, Jiayu Ding, et al.
Pageof 5